Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2015 Jun 08;876:1042-50. doi: 10.1124/mol.115.098111.
Show Gene links
Show Anatomy links
The Link between Inactivation and High-Affinity Block of hERG1 Channels.
Wu W
,
Gardner A
,
Sanguinetti MC
.
???displayArticle.abstract???
Block of human ether-à-go-go-related gene 1 (hERG1) K(+) channels by many drugs delays cardiac repolarization, prolongs QT interval, and is associated with an increased risk of cardiac arrhythmia. Preferential block of hERG1 channels in an inactivated state has been assumed because inactivation deficient mutant channels can exhibit dramatically reduced drug sensitivity. Here we reexamine the link between inactivation gating and potency of channel block using concatenated hERG1 tetramers containing a variable number (0-4) of subunits harboring a point mutation (S620T or S631A) that disrupts inactivation. Concatenated hERG1 tetramers containing four wild-type subunits exhibited high-affinity block by cisapride, dofetilide, and MK-499, similar to wild-type channels formed from hERG1 monomers. A single S620T subunit within a tetramer was sufficient to fully disrupt inactivation gating, whereas S631A suppressed inactivation as a graded function of the number of mutant subunits present in a concatenated tetramer. Drug potency was positively correlated to the number of S620T subunits contained within a tetramer but unrelated to mutation-induced disruption of channel inactivation. Introduction of a second point mutation (Y652W) into S620T hERG1 partially rescued drug sensitivity. The potency of cisapride was not altered for tetramers containing 0 to 3 S631A subunits, whereas the potency of dofetilide was a graded function of the number of S631A subunits contained within a tetramer. Together these findings indicate that S620T or S631A substitutions can allosterically disrupt drug binding by a mechanism that is independent of their effects on inactivation gating.
Abbruzzese,
Modification of hERG1 channel gating by Cd2+.
2010, Pubmed,
Xenbase
Abbruzzese,
Modification of hERG1 channel gating by Cd2+.
2010,
Pubmed
,
Xenbase
Chen,
Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
2002,
Pubmed
,
Xenbase
Cordeiro,
Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
2005,
Pubmed
Curran,
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.
1995,
Pubmed
Fenichel,
Drug-induced torsades de pointes and implications for drug development.
2004,
Pubmed
Fernandez,
Physicochemical features of the HERG channel drug binding site.
2004,
Pubmed
,
Xenbase
Ficker,
Molecular determinants of dofetilide block of HERG K+ channels.
1998,
Pubmed
,
Xenbase
Goldin,
Expression of ion channels by injection of mRNA into Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Guo,
Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
2006,
Pubmed
Hurst,
Potassium channel assembly from concatenated subunits: effects of proline substitutions in S4 segments.
1995,
Pubmed
,
Xenbase
Hurst,
Cooperative interactions among subunits of a voltage-dependent potassium channel. Evidence from expression of concatenated cDNAs.
1992,
Pubmed
,
Xenbase
Imai,
Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach.
2009,
Pubmed
Kamiya,
Molecular determinants of HERG channel block.
2006,
Pubmed
,
Xenbase
Keating,
Molecular and cellular mechanisms of cardiac arrhythmias.
2001,
Pubmed
Lees-Miller,
Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites.
2000,
Pubmed
,
Xenbase
McCormack,
Tandem linkage of Shaker K+ channel subunits does not ensure the stoichiometry of expressed channels.
1992,
Pubmed
,
Xenbase
Mitcheson,
A structural basis for drug-induced long QT syndrome.
2000,
Pubmed
,
Xenbase
Mitcheson,
Molecular determinants of high-affinity drug binding to HERG channels.
2003,
Pubmed
Numaguchi,
Probing the interaction between inactivation gating and Dd-sotalol block of HERG.
2000,
Pubmed
Perrin,
Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-à-go-go-related gene channels.
2008,
Pubmed
Sack,
How to validate a heteromeric ion channel drug target: assessing proper expression of concatenated subunits.
2008,
Pubmed
Sanguinetti,
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
1995,
Pubmed
,
Xenbase
Smith,
The inward rectification mechanism of the HERG cardiac potassium channel.
1996,
Pubmed
Stansfeld,
Insight into the mechanism of inactivation and pH sensitivity in potassium channels from molecular dynamics simulations.
2008,
Pubmed
Stühmer,
Electrophysiological recording from Xenopus oocytes.
1992,
Pubmed
,
Xenbase
Suessbrich,
Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
1997,
Pubmed
,
Xenbase
Trudeau,
HERG, a human inward rectifier in the voltage-gated potassium channel family.
1995,
Pubmed
Wang,
Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation.
1997,
Pubmed
,
Xenbase
Wang,
A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Wu,
Concatenated hERG1 tetramers reveal stoichiometry of altered channel gating by RPR-260243.
2015,
Pubmed
,
Xenbase
Wu,
Cooperative subunit interactions mediate fast C-type inactivation of hERG1 K+ channels.
2014,
Pubmed
,
Xenbase
Wu,
Stoichiometry of altered hERG1 channel gating by small molecule activators.
2014,
Pubmed
,
Xenbase
Zou,
A mutation in the pore region of HERG K+ channels expressed in Xenopus oocytes reduces rectification by shifting the voltage dependence of inactivation.
1998,
Pubmed
,
Xenbase
